Advertisement
Screener

MACROGENICS, INC. (MGNX) Capital Expenditures

2.8 / 5 stars · 68/120 Roast Me

MACROGENICS, INC. Capital Expenditures

MACROGENICS, INC. (MGNX) reported Capital Expenditures of $1.15 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-14

  • MACROGENICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $806.00K, a 12.73% increase year-over-year.
  • MACROGENICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $344.00K, a 34.97% decline year-over-year.
  • MACROGENICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $244.00K, a 60.65% decline year-over-year.
  • MACROGENICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $426.00K, a 28.04% decline year-over-year.
  • MACROGENICS, INC. payments to acquire property, plant, and equipment for fiscal 2025 was $1.91M, a 48.35% decline from fiscal 2024.
  • MACROGENICS, INC. payments to acquire property, plant, and equipment for fiscal 2024 was $3.71M, a 110.09% increase from fiscal 2023.
  • MACROGENICS, INC. payments to acquire property, plant, and equipment for fiscal 2023 was $1.76M, a 51.31% decline from fiscal 2022.
  • MACROGENICS, INC. payments to acquire property, plant, and equipment for fiscal 2022 was $3.62M, a 41.57% decline from fiscal 2021.
Period endPayments to Acquire Property, Plant, and Equipment 3 monthPayments to Acquire Property, Plant, and Equipment 3 month as first filedPayments to Acquire Property, Plant, and Equipment 6 monthPayments to Acquire Property, Plant, and Equipment 9 monthPayments to Acquire Property, Plant, and Equipment 9 month as first filedPayments to Acquire Property, Plant, and Equipment 12 monthPayments to Acquire Property, Plant, and Equipment 12 month as first filed
2026-06-30$806.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14
$1.15M
10-Q · filed 2026-08-14
$1.39M
derived: sum of 3 quarters · filed 2026-08-14
$1.82M
derived: sum of 4 quarters · filed 2026-08-14
2026-03-31$344.00K
10-Q · filed 2026-05-13
$588.00K
derived: sum of 2 quarters · filed 2026-05-13
$1.01M
derived: sum of 3 quarters · filed 2026-05-13
$1.73M
derived: sum of 4 quarters · filed 2026-08-14
2025-12-31$244.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09
$670.00K
derived: sum of 2 quarters · filed 2026-03-09
$1.39M
derived: sum of 3 quarters · filed 2026-08-14
$1.91M
10-K · filed 2026-03-09
2025-09-30$426.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
$1.14M
derived: sum of 2 quarters · filed 2026-08-14
$1.67M
10-Q · filed 2025-11-12
$2.29M
derived: sum of 4 quarters · filed 2026-08-14
2025-06-30$715.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14
$1.24M
10-Q · filed 2026-08-14
$1.86M
derived: sum of 3 quarters · filed 2026-08-14
$2.46M
derived: sum of 4 quarters · filed 2026-08-14
2025-03-31$529.00K
10-Q · filed 2026-05-13
$1.15M
derived: sum of 2 quarters · filed 2026-05-13
$1.74M
derived: sum of 3 quarters · filed 2026-05-13
$2.78M
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31$620.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09
$1.21M
derived: sum of 2 quarters · filed 2026-03-09
$2.25M
derived: sum of 3 quarters · filed 2026-03-09
$3.71M
10-K · filed 2026-03-09
2024-09-30$592.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
$1.63M
derived: sum of 2 quarters · filed 2025-11-12
$3.09M
10-Q · filed 2025-11-12
$3.71M
derived: sum of 4 quarters · filed 2026-03-09
2024-06-30$1.03M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14
$2.49M
10-Q · filed 2025-08-14
$3.11M
derived: sum of 3 quarters · filed 2026-03-09
$3.61M
derived: sum of 4 quarters · filed 2026-03-09
2024-03-31$1.46M
10-Q · filed 2025-05-13
$2.08M
derived: sum of 2 quarters · filed 2026-03-09
$2.58M
derived: sum of 3 quarters · filed 2026-03-09
$2.86M
derived: sum of 4 quarters · filed 2026-03-09
2023-12-31$620.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09
$1.12M
derived: sum of 2 quarters · filed 2026-03-09
$1.41M
derived: sum of 3 quarters · filed 2026-03-09
$1.76M
10-K · filed 2026-03-09
2023-09-30$499.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05
$785.00K
derived: sum of 2 quarters · filed 2024-11-05
$1.14M
10-Q · filed 2024-11-05
$1.54M
derived: sum of 4 quarters · filed 2025-03-20
2023-06-30$286.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06
$645.00K
10-Q · filed 2024-08-06
$1.04M
derived: sum of 3 quarters · filed 2025-03-20
$1.84M
derived: sum of 4 quarters · filed 2025-03-20
2023-03-31$359.00K
10-Q · filed 2024-05-09
$752.00K
derived: sum of 2 quarters · filed 2025-03-20
$1.56M
derived: sum of 3 quarters · filed 2025-03-20
$2.57M
derived: sum of 4 quarters · filed 2025-03-20
2022-12-31$393.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20
$1.20M
derived: sum of 2 quarters · filed 2025-03-20
$2.21M
derived: sum of 3 quarters · filed 2025-03-20
$3.62M
10-K · filed 2025-03-20
2022-09-30$804.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06
$1.81M
derived: sum of 2 quarters · filed 2023-11-06
$3.23M
10-Q · filed 2023-11-06
$4.61M
derived: sum of 4 quarters · filed 2024-03-07
2022-06-30$1.01M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
$2.43M
10-Q · filed 2023-08-09
$3.80M
derived: sum of 3 quarters · filed 2024-03-07
$5.93M
derived: sum of 4 quarters · filed 2024-03-07
2022-03-31$1.42M
10-Q · filed 2023-05-09
$2.79M
derived: sum of 2 quarters · filed 2024-03-07
$4.92M
derived: sum of 3 quarters · filed 2024-03-07
$6.99M
derived: sum of 4 quarters · filed 2024-03-07
2021-12-31$1.38M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07
$3.51M
derived: sum of 2 quarters · filed 2024-03-07
$5.58M
derived: sum of 3 quarters · filed 2024-03-07
$6.20M
10-K · filed 2024-03-07
2021-09-30$2.13M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
$4.20M
derived: sum of 2 quarters · filed 2022-11-03
$4.83M
10-Q · filed 2022-11-03
$8.39M
derived: sum of 4 quarters · filed 2023-03-15
2021-06-30$2.07M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08
$2.69M
10-Q · filed 2022-08-08
$6.25M
derived: sum of 3 quarters · filed 2023-03-15
$6.75M
derived: sum of 4 quarters · filed 2023-03-15
2021-03-31$626.00K
10-Q · filed 2022-05-03
$4.19M
derived: sum of 2 quarters · filed 2023-03-15
$4.68M
derived: sum of 3 quarters · filed 2023-03-15
$5.28M
derived: sum of 4 quarters · filed 2023-03-15
2020-12-31$3.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15
$4.06M
derived: sum of 2 quarters · filed 2023-03-15
$4.65M
derived: sum of 3 quarters · filed 2023-03-15
$5.91M
10-K · filed 2023-03-15
2020-09-30$499.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02
$1.09M
derived: sum of 2 quarters · filed 2021-11-02
$2.35M
10-Q · filed 2021-11-02
$3.59M
derived: sum of 4 quarters · filed 2022-02-24
2020-06-30$594.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29
$1.85M
10-Q · filed 2021-07-29
$3.09M
derived: sum of 3 quarters · filed 2022-02-24
$3.87M
derived: sum of 4 quarters · filed 2022-02-24
2020-03-31$1.25M
10-Q · filed 2021-04-29
$2.50M
derived: sum of 2 quarters · filed 2022-02-24
$3.28M
derived: sum of 3 quarters · filed 2022-02-24
$3.87M
derived: sum of 4 quarters · filed 2022-02-24
2019-12-31$1.25M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
$2.03M
derived: sum of 2 quarters · filed 2022-02-24
$2.61M
derived: sum of 3 quarters · filed 2022-02-24
$4.29M
10-K · filed 2022-02-24
2019-09-30$780.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04
$1.37M
derived: sum of 2 quarters · filed 2020-11-04
$3.04M
10-Q · filed 2020-11-04
$3.76M
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30$587.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31
$2.26M
10-Q · filed 2020-07-31
$2.98M
derived: sum of 3 quarters · filed 2021-02-25
$7.19M
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31$1.68M
10-Q · filed 2020-05-05
$2.39M
derived: sum of 2 quarters · filed 2021-02-25
$6.61M
derived: sum of 3 quarters · filed 2021-02-25
$12.11M
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31$715.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
$4.93M
derived: sum of 2 quarters · filed 2021-02-25
$10.44M
derived: sum of 3 quarters · filed 2021-02-25
$24.95M
10-K · filed 2021-02-25
2018-09-30$4.22M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06
$9.72M
derived: sum of 2 quarters · filed 2019-11-06
$24.24M
10-Q · filed 2019-11-06
$35.00M
derived: sum of 4 quarters · filed 2020-02-25
2018-06-30$5.50M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31
$20.02M
10-Q · filed 2019-07-31
$30.78M
derived: sum of 3 quarters · filed 2020-02-25
$40.63M
derived: sum of 4 quarters · filed 2020-02-25
2018-03-31$14.52M
10-Q · filed 2019-05-01
$25.28M
derived: sum of 2 quarters · filed 2020-02-25
$35.13M
derived: sum of 3 quarters · filed 2020-02-25
$42.43M
derived: sum of 4 quarters · filed 2020-02-25
2017-12-31$10.76M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
$20.61M
derived: sum of 2 quarters · filed 2020-02-25
$27.91M
derived: sum of 3 quarters · filed 2020-02-25
$29.40M
10-K · filed 2020-02-25
2017-09-30$9.85M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07
$17.15M
derived: sum of 2 quarters · filed 2018-11-07
$18.64M
10-Q · filed 2018-11-07
$19.71M
derived: sum of 4 quarters · filed 2019-02-26
2017-06-30$7.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07
$8.79M
10-Q · filed 2018-08-07
$9.86M
derived: sum of 3 quarters · filed 2019-02-26
$11.84M
derived: sum of 4 quarters · filed 2019-02-26
2017-03-31$1.49M
10-Q · filed 2018-05-07
$2.55M
derived: sum of 2 quarters · filed 2019-02-26
$4.53M
derived: sum of 3 quarters · filed 2019-02-26
$10.04M
derived: sum of 4 quarters · filed 2019-02-26
2016-12-31$1.06M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26
$3.04M
derived: sum of 2 quarters · filed 2019-02-26
$8.55M
derived: sum of 3 quarters · filed 2019-02-26
$11.38M
10-K · filed 2019-02-26
2016-09-30$1.98M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08
$7.49M
derived: sum of 2 quarters · filed 2017-11-08
$10.32M
10-Q · filed 2017-11-08
$13.10M
derived: sum of 4 quarters · filed 2018-02-27
2016-06-30$5.51M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02
$8.34M
10-Q · filed 2017-08-02
$11.12M
derived: sum of 3 quarters · filed 2018-02-27
$13.73M
derived: sum of 4 quarters · filed 2018-02-27
2016-03-31$2.83M
10-Q · filed 2017-05-03
$5.61M
derived: sum of 2 quarters · filed 2018-02-27
$8.22M
derived: sum of 3 quarters · filed 2018-02-27
$11.03M
derived: sum of 4 quarters · filed 2018-02-27
2015-12-31$2.78M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27
$5.39M
derived: sum of 2 quarters · filed 2018-02-27
$8.20M
derived: sum of 3 quarters · filed 2018-02-27
$9.20M
10-K · filed 2018-02-27
2015-09-30$2.61M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02
$5.42M
derived: sum of 2 quarters · filed 2016-11-02
$6.42M
10-Q · filed 2016-11-02
$8.07M
derived: sum of 4 quarters · filed 2017-02-28
2015-06-30$2.81M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03
$3.81M
10-Q · filed 2016-08-03
$5.47M
derived: sum of 3 quarters · filed 2017-02-28
$6.14M
derived: sum of 4 quarters · filed 2017-02-28
2015-03-31$997.00K
10-Q · filed 2016-05-04
$2.65M
derived: sum of 2 quarters · filed 2017-02-28
$3.33M
derived: sum of 3 quarters · filed 2017-02-28
$4.12M
derived: sum of 4 quarters · filed 2017-02-28
2014-12-31$1.66M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28
$2.33M
derived: sum of 2 quarters · filed 2017-02-28
$3.13M
derived: sum of 3 quarters · filed 2017-02-28
$3.57M
10-K · filed 2017-02-28
2014-09-30$672.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04
$1.47M
derived: sum of 2 quarters · filed 2015-11-04
$1.91M
10-Q · filed 2015-11-04
$2.84M
derived: sum of 4 quarters · filed 2016-02-29
2014-06-30$795.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05
$1.24M
10-Q · filed 2015-08-05
$2.17M
derived: sum of 3 quarters · filed 2016-02-29
$3.33M
derived: sum of 4 quarters · filed 2016-02-29
2014-03-31$447.00K
10-Q · filed 2015-05-06
$447.27K
10-Q · filed 2014-05-06
$1.37M
derived: sum of 2 quarters · filed 2016-02-29
$2.53M
derived: sum of 3 quarters · filed 2016-02-29
$2.98M
derived: sum of 4 quarters · filed 2016-02-29
2013-12-31$924.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
$2.08M
derived: sum of 2 quarters · filed 2016-02-29
$2.54M
derived: sum of 3 quarters · filed 2016-02-29
$2.96M
10-K · filed 2016-02-29
$2.96M
10-K · filed 2014-03-20
2013-09-30$1.16M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12
$1.61M
derived: sum of 2 quarters · filed 2014-11-12
$2.04M
10-Q · filed 2014-11-12
$2.04M
10-Q · filed 2013-11-12
$2.45M
derived: sum of 4 quarters · filed 2015-03-03
2013-06-30$450.91K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05
$876.00K
10-Q · filed 2014-08-05
$1.29M
derived: sum of 3 quarters · filed 2015-03-03
2013-03-31$425.09K
10-Q · filed 2014-05-06
$834.96K
derived: sum of 2 quarters · filed 2015-03-03
2012-12-31$409.86K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-03
$940.00K
10-K · filed 2015-03-03
$940.04K
10-K · filed 2014-03-20
2012-09-30$530.14K
10-Q · filed 2013-11-12
2011-12-31$500.21K
10-K · filed 2014-03-20

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cue Biopharma, Inc. (CUE)United States$0.243B-1.01
Entrada Therapeutics, Inc. (TRDA)United States$0.243B-1.73
Pyxis Oncology, Inc. (PYXS)United States$0.244B
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12
Lyell Immunopharma, Inc. (LYEL)United States$0.248B-1.32
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33
Cartesian Therapeutics, Inc. (RNAC)United States$0.231B-2.04
Keros Therapeutics, Inc. (KROS)United States$0.229B-2.55
Akebia Therapeutics, Inc. (AKBA)United States$0.255B-10.35